STOCKWATCH
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultMay 13, 2026, 08:12 AM

Astrotech Q3 Revenue Down 36% to $343K; Net Loss $(3.77)M

AI Summary

Astrotech Corporation reported a significant decline in financial results for the third quarter of fiscal year 2026, with revenue decreasing by 36% to $343 thousand and net loss increasing to $(3.77) million from $(3.63) million in the prior year. Gross profit also saw a substantial drop of 72% to $67 thousand. Despite the financial downturn, the company highlighted a 28% reduction in research and development expenses as it transitions to saleable products and noted the deployment of its TRACER 1000 system in 37 locations across 16 countries. The CEO emphasized disciplined execution, cost-efficiency, and a healthy sales pipeline.

Key Highlights

  • Q3 FY2026 revenue decreased 36% to $343 thousand from $534 thousand YoY.
  • Q3 FY2026 net loss increased to $(3.77) million from $(3.63) million YoY.
  • Q3 FY2026 gross profit declined 72% to $67 thousand from $237 thousand YoY.
  • Research and development expense decreased 28% to $1.44 million YoY.
  • TRACER 1000 system deployed in 37 locations across 16 countries.
  • Total assets decreased to $16.17 million from $26.99 million since June 30, 2025.
  • Short-term investments significantly reduced to $3.90 million from $15.11 million.
ASTC
Biotechnology: Laboratory Analytical Instruments
ASTROTECH Corp

Price Impact